Benefits and risks of bisphosphonate therapy for osteoporosis: Editorial comment

Sundeep Khosla, John P. Bilezikian, David W. Dempster, E. Michael Lewiecki, Paul D. Miller, Robert M. Neer, Robert R. Recker, Elizabeth Shane, Dolores Shoback, John T. Potts

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)37-39
Number of pages3
JournalObstetrical and Gynecological Survey
Volume68
Issue number1
DOIs
StatePublished - Jan 1 2013

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Khosla, S., Bilezikian, J. P., Dempster, D. W., Lewiecki, E. M., Miller, P. D., Neer, R. M., Recker, R. R., Shane, E., Shoback, D., & Potts, J. T. (2013). Benefits and risks of bisphosphonate therapy for osteoporosis: Editorial comment. Obstetrical and Gynecological Survey, 68(1), 37-39. https://doi.org/10.1097/01.ogx.0000426495.05172.0f